RASSF1D inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RASSF1D, one of the alternative spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. RASSF1, a critical gene involved in cellular regulation, produces multiple isoforms through alternative splicing, each with distinct roles in modulating pathways related to apoptosis, cell cycle control, and cytoskeletal organization. RASSF1D, like its sibling isoforms, interacts with Ras GTPases and other signaling proteins to influence crucial cellular processes, such as cell proliferation and programmed cell death. RASSF1D plays a unique role within these pathways, potentially having distinct regulatory functions compared to other isoforms. Inhibitors of RASSF1D function by binding to key regions of the protein, disrupting its ability to participate in protein-protein interactions and preventing it from influencing the signaling pathways it normally modulates.
The inhibition of RASSF1D leads to changes in the cellular processes it regulates, particularly in relation to apoptosis and the maintenance of cell cycle checkpoints. By blocking RASSF1D's involvement in these pathways, the inhibitors prevent the normal regulation of signals that determine cell fate, potentially causing shifts in cellular growth, differentiation, or survival. Researchers use RASSF1D inhibitors to explore the specific contributions of this isoform to cellular signaling networks, allowing for a deeper understanding of how alternative splicing in the RASSF1 gene results in functionally distinct proteins. These inhibitors also provide insights into how RASSF1D modulates Ras-related signaling pathways and contributes to the fine-tuning of cellular responses to environmental stimuli. The study of RASSF1D inhibitors helps illuminate the broader regulatory mechanisms that govern apoptosis, cell cycle progression, and cytoskeletal dynamics, offering valuable knowledge about the molecular pathways responsible for maintaining cellular balance and integrity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into DNA during the S-phase, 5-Azacytidine can cause demethylation, potentially leading to the downregulation of RASSF1D if its promoter region is subject to methylation control. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid inhibits histone deacetylases, which could lead to alterations in chromatin structure around the RASSF1D gene, potentially resulting in decreased transcriptional activity of RASSF1D. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine selectively inhibits DNA methyltransferases, which may cause hypomethylation of the RASSF1D gene promoter, potentially resulting in its transcriptional repression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By selectively inhibiting histone deacetylase, Trichostatin A could cause hyperacetylation of histones near the RASSF1D gene, potentially leading to a decrease in RASSF1D expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, which can then bind to retinoic acid response elements in gene promoters, potentially repressing RASSF1D transcription if such elements exist upstream of the RASSF1D gene. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate interferes with folate metabolism, which could indirectly lead to the suppression of RASSF1D through disruption of the methyl donor pool necessary for DNA methylation. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to DNA damage and potential suppression of DNA replication-related genes, including possibly RASSF1D if it is associated with replication stress responses. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to GC-rich sequences in DNA, potentially blocking transcription factor access to promoters; this could result in the inhibition of RASSF1D expression if its promoter contains such GC-rich regions. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram can chelate copper, forming a complex that inhibits the proteasomal degradation pathway, potentially leading to the accumulation of regulatory proteins that could suppress RASSF1D transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin is known to inhibit NF-κB, a transcription factor that regulates many genes; this inhibition could extend to the RASSF1D gene if NF-κB is involved in its expression. | ||||||